Pharmacokinetics and bioavailability of herbal medicinal products.
暂无分享,去创建一个
[1] T. Walle,et al. Induction of UDP-Glucuronosyl-Transferase by the Flavonoids Chrysin and Quercetin in Caco-2 Cells , 2004, Pharmaceutical Research.
[2] H. Derendorf,et al. Systemic Availability and Pharmacokinetics of Thymol in Humans , 2002 .
[3] H. Mascher,et al. Pharmacokinetics of Menthol and Carvone after Administration of an Enteric Coated Formulation Containing Peppermint Oil and Caraway Oil , 2001, Arzneimittelforschung.
[4] D. Greenblatt,et al. Saint John's wort: An in vitro analysis of P‐glycoprotein induction due to extended exposure , 2001, British journal of pharmacology.
[5] C. Funck-Brentano,et al. Effect of grapefruit juice on digoxin pharmacokinetics in humans , 2001, Clinical pharmacology and therapeutics.
[6] Shiew-Mei Huang,et al. The effects of St John's wort (Hypericum perforatum) on human cytochrome P450 activity , 2001, Clinical pharmacology and therapeutics.
[7] P. Halushka,et al. Carbon dioxide is the major metabolite of quercetin in humans. , 2001, The Journal of nutrition.
[8] A. Beer,et al. Johanniskraut: Interaktion mit Cyclosporin gefährdet Nierentransplantat und erhöht die täglichen Medikationskosten , 2001, Medizinische Klinik.
[9] A. Aro,et al. Tea and coronary heart disease: the flavonoid quercetin is more bioavailable from rutin in women than in men. , 2001, Archives of internal medicine.
[10] W. Sly,et al. Flavonoid glucuronides are substrates for human liver β‐glucuronidase , 2001 .
[11] G. Williamson,et al. Biomarkers for exposure to dietary flavonoids: a review of the current evidence for identification of quercetin glycosides in plasma , 2001, British Journal of Nutrition.
[12] C. Manach,et al. Comparison of the intestinal absorption of quercetin, phloretin and their glucosides in rats. , 2001, The Journal of nutrition.
[13] L. Heide,et al. Pharmacokinetics of salicin after oral administration of a standardised willow bark extract , 2001, European Journal of Clinical Pharmacology.
[14] K. O'Leary,et al. Quercetin glucuronides but not glucosides are present in human plasma after consumption of quercetin-3-glucoside or quercetin-4'-glucoside. , 2001, The Journal of nutrition.
[15] N. Banner,et al. Low cyclosporin-A level due to Saint-John's-wort in heart transplant patients. , 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[16] R. Pandey,et al. BMI does not accurately predict overweight in Asian Indians in northern India. , 2001, The British journal of nutrition.
[17] C. Gardana,et al. Liquid chromatography/atmospheric pressure chemical ionization mass spectrometry of terpene lactones in plasma of volunteers dosed with Ginkgo biloba L. extracts. , 2001, Rapid communications in mass spectrometry : RCM.
[18] S. Kasper,et al. Hypericum perforatum - a Review of Clinical Studies , 2001, Pharmacopsychiatry.
[19] E. Ernst,et al. St John's wort: Prozac from the plant kingdom. , 2001, Trends in pharmacological sciences.
[20] J. Drewe,et al. [St. John's wort: a pharmaceutical with potentially dangerous interactions]. , 2001, Praxis.
[21] M Elvin-Lewis,et al. Should we be concerned about herbal remedies. , 2001, Journal of ethnopharmacology.
[22] J. Phillipson,et al. St John's wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties , 2001, The Journal of pharmacy and pharmacology.
[23] G. Jacobasch,et al. Pharmacokinetics and Bioavailability of Quercetin Glycosides in Humans , 2001, Journal of clinical pharmacology.
[24] A. Bilia,et al. Analysis of plant complex matrices by use of nuclear magnetic resonance spectroscopy: St. John's wort extract. , 2001, Journal of agricultural and food chemistry.
[25] M. Herderich,et al. Identification of quercetin glucuronides in human plasma by high-performance liquid chromatography-tandem mass spectrometry. , 2001, Journal of chromatography. B, Biomedical sciences and applications.
[26] J. L. Greger. Dietary supplement use: consumer characteristics and interests. , 2001, The Journal of nutrition.
[27] G. Mahady. Global harmonization of herbal health claims. , 2001, The Journal of nutrition.
[28] Y. Chen,et al. Quercetin inhibits the expression and function of the androgen receptor in LNCaP prostate cancer cells. , 2001, Carcinogenesis.
[29] J. Beijnen,et al. Drug interaction between St John's wort and nevirapine. , 2001, AIDS.
[30] R. Meuli,et al. Quantitative assessment of regional cerebral blood flows by perfusion CT studies at low injection rates: a critical review of the underlying theoretical models , 2001, European Radiology.
[31] J. Kepa,et al. Induction of human NAD(P)H:quinone oxidoreductase (NQO1) gene expression by the flavonol quercetin. , 2001, Toxicology letters.
[32] Hong-Xi Xu,et al. Activity of plant flavonoids against antibiotic‐resistant bacteria , 2001, Phytotherapy research : PTR.
[33] A. Bilia,et al. Evaluation of chemical stability of St. John's wort commercial extract and some preparations. , 2001, International journal of pharmaceutics.
[34] A. Prince,et al. Pharmacokinetics, Safety, and Antiviral Effects of Hypericin, a Derivative of St. John's Wort Plant, in Patients with Chronic Hepatitis C Virus Infection , 2001, Antimicrobial Agents and Chemotherapy.
[35] S. Wolffram,et al. Interaction of quercetin glucosides with the intestinal sodium/glucose co-transporter (SGLT-1). , 2001, Cancer letters.
[36] J. Greeson,et al. St. John's wort (Hypericum perforatum): a review of the current pharmacological, toxicological, and clinical literature , 2001, Psychopharmacology.
[37] P. Nathan. Hypericum perforatum (St John's Wort): a non-selective reuptake inhibitor? A review of the recent advances in its pharmacology , 2001, Journal of psychopharmacology.
[38] P. Cullinan,et al. Cyclosporin as an oral corticosteroid sparing agent in stable asthma. , 2000, The Cochrane database of systematic reviews.
[39] S. Chrubasik,et al. Potential economic impact of using a proprietary willow bark extract in outpatient treatment of low back pain: an open non-randomized study. , 2001, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[40] N. Luepke,et al. Evidence for toxic effects of alkylphenols from Ginkgo biloba in the hen's egg test (HET). , 2001, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[41] G. Barbero,et al. Enteric-coated, pH-dependent peppermint oil capsules for the treatment of irritable bowel syndrome in children. , 2001, The Journal of pediatrics.
[42] P. Adamson,et al. Plasma pharmacokinetics and cerebrospinal fluid penetration of hypericin in nonhuman primates , 2001, Cancer Chemotherapy and Pharmacology.
[43] Honglu Zhang,et al. A method for the simultaneous evaluation of the activities of seven major human drug-metabolizing cytochrome P450s using an in vitro cocktail of probe substrates and fast gradient liquid chromatography tandem mass spectrometry. , 2001, Drug metabolism and disposition: the biological fate of chemicals.
[44] J. Evans. Ginkgo biloba extract for age-related macular degeneration. , 2013, The Cochrane database of systematic reviews.
[45] E. Elstner,et al. Antioxidant properties of essential oils. Possible explanations for their anti-inflammatory effects. , 2011, Arzneimittel-Forschung.
[46] O. Petrini,et al. Efficacy of Orally Administered Extract of Red Vine Leaf AS 195 (folia vitis viniferae) in Chronic Venous Insufficiency (Stages l-ll) , 2000, Arzneimittelforschung.
[47] H. Matthys,et al. Efficacy and Tolerability of Myrtol Standardized in Acute Bronchitis , 2000, Arzneimittelforschung.
[48] G. Williamson,et al. Conjugation position of quercetin glucuronides and effect on biological activity. , 2000, Free radical biology & medicine.
[49] W. Pöldinger. [History of St. Johns wort]. , 2000, Praxis.
[50] W. Müller,et al. [Mechanism of action of St. Johns wort extract]. , 2000, Praxis.
[51] D. Savio,et al. Oral bioavailability of active principles from herbal products in humans. A study on Hypericum perforatum extracts using the soft gelatin capsule technology. , 2000, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[52] P. Meier,et al. St John's Wort induces intestinal P‐glycoprotein/MDR1 and intestinal and hepatic CYP3A4 , 2000, Clinical pharmacology and therapeutics.
[53] S. Piscitelli,et al. Lack of effect of St John's Wort on carbamazepine pharmacokinetics in healthy volunteers , 2000, Clinical pharmacology and therapeutics.
[54] S. Walker,et al. Determination of hypericin and pseudohypericin in pharmaceutical preparations by liquid chromatography with fluorescence detection. , 2000, Journal of chromatography. B, Biomedical sciences and applications.
[55] T. Therneau,et al. Silymarin in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid , 2000, Hepatology.
[56] T. Walle,et al. Quercetin glucosides are completely hydrolyzed in ileostomy patients before absorption. , 2000, The Journal of nutrition.
[57] G. Williamson,et al. Intestinal transport of quercetin glycosides in rats involves both deglycosylation and interaction with the hexose transport pathway. , 2000, The Journal of nutrition.
[58] K. Wesnes,et al. The memory enhancing effects of a Ginkgo biloba/Panax ginseng combination in healthy middle-aged volunteers , 2000, Psychopharmacology.
[59] S. Strom,et al. Milk thistle, a herbal supplement, decreases the activity of CYP3A4 and uridine diphosphoglucuronosyl transferase in human hepatocyte cultures. , 2000, Drug metabolism and disposition: the biological fate of chemicals.
[60] H. Selbmann,et al. Wirksamkeit und Verträglichkeit eines standardisierten Weidenrindenextraktes bei Arthrose-Patienten: Randomisierte, Placebo-kontrollierte Doppelblindstudie , 2000, Zeitschrift für Rheumatologie.
[61] R. Agarwal,et al. Cell signaling and regulators of cell cycle as molecular targets for prostate cancer prevention by dietary agents. , 2000, Biochemical pharmacology.
[62] R. Agarwal,et al. Silibinin up-regulates insulin-like growth factor-binding protein 3 expression and inhibits proliferation of androgen-independent prostate cancer cells. , 2000, Cancer research.
[63] A. Aro,et al. Pharmacokinetics of quercetin from quercetin aglycone and rutin in healthy volunteers , 2000, European Journal of Clinical Pharmacology.
[64] P. Knipschild,et al. The Efficacy of Ginkgo for Elderly People with Dementia and Age‐Associated Memory Impairment: New Results of a Randomized Clinical Trial , 2000, Journal of the American Geriatrics Society.
[65] V. Dobson,et al. Bioavailability and efficiency of rutin as an antioxidant: a human supplementation study , 2000, European Journal of Clinical Nutrition.
[66] R. Agarwal,et al. Anti-angiogenic potential of a cancer chemopreventive flavonoid antioxidant, silymarin: inhibition of key attributes of vascular endothelial cells and angiogenic cytokine secretion by cancer epithelial cells. , 2000, Biochemical and biophysical research communications.
[67] R. März,et al. Measurement of the bioavailability of aescin-containing extracts. , 2000, Methods and findings in experimental and clinical pharmacology.
[68] J. Sprung,et al. A possible cause of cardiovascular collapse during anesthesia: long-term use of St. John's Wort. , 2000, Journal of clinical anesthesia.
[69] Y. Arai,et al. Dietary intakes of flavonols, flavones and isoflavones by Japanese women and the inverse correlation between quercetin intake and plasma LDL cholesterol concentration. , 2000, The Journal of nutrition.
[70] R. Beger,et al. Evaluation of major active components in St. John's Wort dietary supplements by high-performance liquid chromatography with photodiode array detection and electrospray mass spectrometric confirmation. , 2000, Journal of chromatography. A.
[71] G. D. Renzo. Ginkgo biloba and the central nervous system. , 2000 .
[72] T. Inakuma,et al. Accumulation of quercetin conjugates in blood plasma after the short-term ingestion of onion by women. , 2000, American journal of physiology. Regulatory, integrative and comparative physiology.
[73] E. Eisenberg,et al. Treatment of low back pain exacerbations with willow bark extract: a randomized double-blind study. , 2000, American Journal of Medicine.
[74] J. Wolfender,et al. Determination of trace amounts of ginkgolic acids in Ginkgo biloba L. leaf extracts and phytopharmaceuticals by liquid chromatography-electrospray mass spectrometry. , 2000, Journal of chromatography. B, Biomedical sciences and applications.
[75] A. Heck,et al. Potential interactions between alternative therapies and warfarin. , 2000, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[76] R. Obach,et al. Inhibition of human cytochrome P450 enzymes by constituents of St. John's Wort, an herbal preparation used in the treatment of depression. , 2000, The Journal of pharmacology and experimental therapeutics.
[77] K. Z. Itil,et al. A 26-Week Analysis of a Double-Blind, Placebo-Controlled Trial of the Ginkgo biloba Extract EGb 761® in Dementia , 2000, Dementia and Geriatric Cognitive Disorders.
[78] L. Moore,et al. St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[79] U. Fuhr,et al. Inhibitory effects of silibinin on cytochrome P-450 enzymes in human liver microsomes. , 2000, Pharmacology & toxicology.
[80] W. Merlevede,et al. Photocytotoxicity of hypericin in normoxic and hypoxic conditions. , 2000, Journal of photochemistry and photobiology. B, Biology.
[81] D. Lamson,et al. Antioxidants and cancer, part 3: quercetin. , 2000, Alternative medicine review : a journal of clinical therapeutic.
[82] T. Vree,et al. Human Nutrition and Metabolism—Research Communication Bioavailabilities of Quercetin-3- Glucoside and Quercetin-4*- Glucoside Do Not Differ in Humans , 2000 .
[83] G. Frisoni,et al. Coma in a patient with Alzheimer's disease taking low dose trazodone and ginkgo biloba , 2000, Journal of neurology, neurosurgery, and psychiatry.
[84] S. Wolffram,et al. Bioavailability and metabolism of the flavonol quercetin in the pig. , 2000, Free radical biology & medicine.
[85] M. Godejohann,et al. Application of directly coupled HPLC-NMR-MS to the identification and confirmation of quercetin glycosides and phloretin glycosides in apple peel. , 2000, Analytical chemistry.
[86] B. D. Gupta,et al. Anti-inflammatory and anti-arthritic activities of silymarin acting through inhibition of 5-lipoxygenase. , 2000, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[87] N. Vynograd,et al. A comparative multi-centre study of the efficacy of propolis, acyclovir and placebo in the treatment of genital herpes (HSV). , 2000, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[88] G. Williamson,et al. Dietary flavonoid and isoflavone glycosides are hydrolysed by the lactase site of lactase phlorizin hydrolase , 2000, FEBS letters.
[89] J. Falloon,et al. Indinavir concentrations and St John's wort , 2000, The Lancet.
[90] Q. Yue,et al. Safety of St John's wort (Hypericum perforatum) , 2000, The Lancet.
[91] F. Ruschitzka,et al. Acute heart transplant rejection due to Saint John's wort , 2000, The Lancet.
[92] G. Micklefield,et al. Effects of peppermint oil and caraway oil on gastroduodenal motility , 2000, Phytotherapy research : PTR.
[93] S. Risch,et al. Effect of St. John's wort (Hypericum perforatum) on cytochrome P-450 2D6 and 3A4 activity in healthy volunteers. , 2000, Life sciences.
[94] A. di Pietro,et al. The flavanolignan silybin and its hemisynthetic derivatives, a novel series of potential modulators of P-glycoprotein. , 2000, Bioorganic & medicinal chemistry letters.
[95] P. Agostinis,et al. Apoptotic and anti-apoptotic signaling pathways induced by photodynamic therapy with hypericin. , 2000, Advances in enzyme regulation.
[96] C. Rémésy,et al. Respective bioavailability of quercetin aglycone and its glycosides in a rat model. , 2000, BioFactors.
[97] M. Piskuła. Factors affecting flavonoids absorption. , 2000, BioFactors.
[98] A. Madisch,et al. Treatment of Functional Dyspepsia with a Fixed Peppermint Oil and Caraway Oil Combination Preparation as Compared to Cisapride , 1999, Arzneimittelforschung.
[99] C. D. De Mey,et al. Efficacy and Tolerability of Myrtol Standardized in Long-term Treatment of Chronic Bronchitis , 1999, Arzneimittelforschung.
[100] E. Ernst,et al. Second thoughts about safety of St John's wort , 1999, The Lancet.
[101] P. Hollman,et al. The sugar moiety is a major determinant of the absorption of dietary flavonoid glycosides in man. , 1999, Free radical research.
[102] R. Agarwal,et al. Tissue distribution of silibinin, the major active constituent of silymarin, in mice and its association with enhancement of phase II enzymes: implications in cancer chemoprevention. , 1999, Carcinogenesis.
[103] I. Wilson,et al. High-Performance Liquid Chromatography On-Line Coupled to High-Field NMR and Mass Spectrometry for Structure Elucidation of Constituents of Hypericum perforatum L. , 1999 .
[104] J. Terao,et al. Flavonoids and membrane lipid peroxidation inhibition. , 1999, Nutrition.
[105] I. Roots,et al. Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum) , 1999, Clinical pharmacology and therapeutics.
[106] C. Rice-Evans,et al. The small intestine can both absorb and glucuronidate luminal flavonoids , 1999, FEBS letters.
[107] S. Deans,et al. Dietary supplementation of thyme (Thymus vulgaris L.) essential oil during the lifetime of the rat: its effects on the antioxidant status in liver, kidney and heart tissues , 1999, Mechanisms of Ageing and Development.
[108] M. Marino,et al. Antimicrobial activity of the essential oils of Thymus vulgaris L. measured using a bioimpedometric method. , 1999, Journal of food protection.
[109] J. Simon,et al. Hypericin Levels in Human Serum and Interstitial Skin Blister Fluid after Oral Single-Dose and Steady-State Administration of Hypericum perforatum Extract (St. John’s Wort) , 1999, Skin Pharmacology and Physiology.
[110] C. Rice-Evans,et al. Urinary excretion of hydroxycinnamates and flavonoids after oral and intravenous administration. , 1999, Free radical biology & medicine.
[111] J. Remacle,et al. Protection of mitochondrial respiration activity by bilobalide. , 1999, Biochemical pharmacology.
[112] C. Manach,et al. Part of quercetin absorbed in the small intestine is conjugated and further secreted in the intestinal lumen. , 1999, The American journal of physiology.
[113] J. Simon,et al. Antibacterial activity of hyperforin from St John's wort, against multiresistant Staphylococcus aureus and gram-positive bacteria , 1999, The Lancet.
[114] H. Matsuda,et al. Gastroprotections of escins Ia, Ib, IIa, and IIb on ethanol-induced gastric mucosal lesions in rats. , 1999, European journal of pharmacology.
[115] M. Veit,et al. Pharmacokinetics and bioavailability of the flavonol quercetin in humans. , 1999, International journal of clinical pharmacology and therapeutics.
[116] D. Kroll,et al. Potential Metabolic Interaction between St. John's Wort and Theophylline , 1999, The Annals of pharmacotherapy.
[117] E. Koch,et al. Bioavailability of Ginkgolides and Bilobalide from Extracts of Ginkgo biloba using GC/MS , 1999, Planta medica.
[118] S. Köhler,et al. [Peppermint oil-caraway oil fixed combination in non-ulcer dyspepsia--comparison of the effects of enteric preparations]. , 1999, Die Pharmazie.
[119] G. Mazzanti,et al. Determination of silymarine in the extract from the dried silybum marianum fruits by high performance liquid chromatography and capillary electrophoresis. , 1999, Journal of pharmaceutical and biomedical analysis.
[120] Y. Poovorawan,et al. Fatal mushroom poisoning caused by Amanita virosa in Thailand. , 1999, The Southeast Asian journal of tropical medicine and public health.
[121] E. J. Oliveira,et al. Solid-phase extraction and gas chromatography-mass spectrometry determination of kaempferol and quercetin in human urine after consumption of Ginkgo biloba tablets. , 1999, Journal of chromatography. B, Biomedical sciences and applications.
[122] I. Young,et al. Absorption and antioxidant effects of quercetin from onions, in man , 1999, European Journal of Clinical Nutrition.
[123] L. Dragsted,et al. Differential effects of dietary flavonoids on drug metabolizing and antioxidant enzymes in female rat. , 1999, Xenobiotica; the fate of foreign compounds in biological systems.
[124] L. Dragsted,et al. Effect of fruit juice intake on urinary quercetin excretion and biomarkers of antioxidative status , 1999 .
[125] H. Matsuda,et al. Bioactive saponins and glycosides. XII. Horse chestnut. (2): Structures of escins IIIb, IV, V, and VI and isoescins Ia, Ib, and V, acylated polyhydroxyoleanene triterpene oligoglycosides, from the seeds of horse chestnut tree (Aesculus hippocastanum L., Hippocastanaceae). , 1998, Chemical & pharmaceutical bulletin.
[126] G. Basso,et al. Softgel capsule technology as an enhancer device for the absorption of natural principles in humans. A bioavailability cross-over randomised study on silybin. , 1998, Arzneimittel-Forschung.
[127] E. Ernst,et al. Horse-chestnut seed extract for chronic venous insufficiency. A criteria-based systematic review. , 1998, Archives of dermatology.
[128] K. Kemper,et al. A review of 12 commonly used medicinal herbs. , 1998, Archives of family medicine.
[129] P. Champéroux,et al. Interference of myrtol standardized with inflammatory and allergic mediators. , 1998, Arzneimittel-Forschung.
[130] C. D. De Mey,et al. [Myrtol standardized in the treatment of acute and chronic respiratory infections in children. A multicenter post-marketing surveillance study]. , 1998, Arzneimittel-Forschung.
[131] G Williamson,et al. Deglycosylation of flavonoid and isoflavonoid glycosides by human small intestine and liver β‐glucosidase activity , 1998, FEBS letters.
[132] D. Loew,et al. [The validity of radioimmunologic determination of bioavailability of beta-escin in horse chestnut extracts]. , 1998, Arzneimittel-Forschung.
[133] E. Samcová,et al. Bioavailability of escin after administration of two oral formulations containing aesculus extract. , 1998, Arzneimittel-Forschung.
[134] I. Johnson,et al. Quercetin glucosides interact with the intestinal glucose transport pathway. , 1998, Free radical biology & medicine.
[135] Yeong Shik Kim,et al. Antiplatelet and antithrombotic effects of a combination of ticlopidine and ginkgo biloba ext (EGb 761). , 1998, Thrombosis research.
[136] E. Ernst,et al. Peppermint oil for irritable bowel syndrome: a critical review and metaanalysis , 1998, American Journal of Gastroenterology.
[137] S. Chatterjee,et al. Oral Bioavailability of Hyperforin from Hypericum Extracts in Rats and Human Volunteers , 1998, Pharmacopsychiatry.
[138] U. Hafner,et al. Hyperforin represents the neurotransmitter reuptake inhibiting constituent of hypericum extract. , 1998, Pharmacopsychiatry.
[139] O. Texier,et al. Quercetin is recovered in human plasma as conjugated derivatives which retain antioxidant properties , 1998, FEBS letters.
[140] B. Holub,et al. Supplementation with quercetin markedly increases plasma quercetin concentration without effect on selected risk factors for heart disease in healthy subjects. , 1998, The Journal of nutrition.
[141] T. Walle,et al. Extensive Binding of the Bioflavonoid Quercetin to Human Plasma Proteins , 1998, The Journal of pharmacy and pharmacology.
[142] J. Reyes,et al. Prevention of alloxan-induced diabetes mellitus in the rat by silymarin. , 1998, Comparative biochemistry and physiology. Part C, Pharmacology, toxicology & endocrinology.
[143] R. Freyer. Nachlese zur 32. Jahrestagung , 1998 .
[144] N. Škottová,et al. Silymarin as a potential hypocholesterolaemic drug. , 1998, Physiological research.
[145] E. Ernst,et al. A controlled multi-centre study of herbal versus synthetic secretolytic drugs for acute bronchitis. , 1997, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[146] Chang Li,et al. The Bioavailability of Ginkgolides in Ginkgo biloba Extracts , 1997, Planta medica.
[147] C. Holden. Haensel Wins Draper Prize , 1997, Science.
[148] H. Matsuda,et al. Effects of escins Ia, Ib, IIa, and IIb from horse chestnut, the seeds of Aesculus hippocastanum L., on acute inflammation in animals. , 1997, Biological & pharmaceutical bulletin.
[149] E. Koch,et al. Chemistry and biology of alkylphenols from Ginkgo biloba L. , 1997, Die Pharmazie.
[150] A. Nahrstedt,et al. Biologically Active and Other Chemical Constituents of the Herb of Hypericum perforatum L. , 1997, Pharmacopsychiatry.
[151] U. Hafner,et al. Effects of hypericum extract (LI 160) in biochemical models of antidepressant activity. , 1997, Pharmacopsychiatry.
[152] J. Brockmöller,et al. Hypericin and Pseudohypericin: Pharmacokinetics and Effects on Photosensitivity in Humans , 1997, Pharmacopsychiatry.
[153] K. Zeller,et al. Determination of naphthodianthrones in plant extracts from Hypericum perforatum L. by liquid chromatography-electrospray mass spectrometry. , 1997, Journal of chromatography. B, Biomedical sciences and applications.
[154] O. Texier,et al. Bioavailability of rutin and quercetin in rats , 1997, FEBS letters.
[155] J. Brouwers,et al. Pharmacokinetic Evaluation of Herbal Remedies , 1997, Clinical pharmacokinetics.
[156] C. Gardana,et al. Identification of Gingko biloba flavonol metabolites after oral administration to humans. , 1997, Journal of chromatography. B, Biomedical sciences and applications.
[157] K. Singh,et al. Effects of silymarin on UDP-glucuronic acid and glucuronidation activity in the rat isolated hepatocytes and liver in relation to D-galactosamine toxicity. , 1997, Indian journal of experimental biology.
[158] P. Federspil,et al. Wirkung von Myrtol standardisiert* bei der Therapie der akuten Sinusitis - Ergebnisse einer doppelblinden, randomisierten Multicenterstudie gegen Plazebo , 1997 .
[159] L. Favari,et al. Effect of portal vein ligation and silymarin treatment on aspirin metabolism and disposition in rats. , 1997, Biopharmaceutics & drug disposition.
[160] M. Kieser,et al. Efficacy of a fixed peppermint oil/caraway oil combination in non-ulcer dyspepsia. , 1996, Arzneimittel-Forschung.
[161] J. Magdalou,et al. Comparative effects of flavonoids and model inducers on drug-metabolizing enzymes in rat liver. , 1996, Toxicology.
[162] P. Hollman,et al. Fluorescence detection of flavonols in HPLC by postcolumn chelation with aluminum. , 1996, Analytical chemistry.
[163] J. Brockmöller,et al. Single-dose and steady-state pharmacokinetics of hypericin and pseudohypericin , 1996, Antimicrobial agents and chemotherapy.
[164] C. Mulrow,et al. St John's wort for depression—an overview and meta-analysis of randomised clinical trials , 1996, BMJ.
[165] H. Göbel,et al. [Effectiveness of Oleum menthae piperitae and paracetamol in therapy of headache of the tension type]. , 1996, Der Nervenarzt.
[166] A. Biber,et al. [Pharmaokinetics of beta-escin after administration of various Aesculus extract containing formulations]. , 1996, Die Pharmazie.
[167] A. Beesley,et al. Influence of peppermint oil on absorptive and secretory processes in rat small intestine. , 1996, Gut.
[168] W. Jäger,et al. Pharmacokinetic studies of the fragrance compound 1,8-cineol in humans during inhalation. , 1996, Chemical senses.
[169] O. Texier,et al. Dietary quercetin is recovered in rat plasma as conjugated derivatives of isorhamnetin and quercetin , 1996 .
[170] P. Klein,et al. Comparative clinical efficacy and tolerability of oxerutins and horse chestnut extract in patients with chronic venous insufficiency. , 1996, Arzneimittel-Forschung.
[171] Paul F. Smith,et al. The neuroprotective properties of the Ginkgo biloba leaf: a review of the possible relationship to platelet-activating factor (PAF). , 1996, Journal of ethnopharmacology.
[172] C. Diehm,et al. Comparison of leg compression stocking and oral horse-chestnut seed extract therapy in patients with chronic venous insufficiency , 1996, The Lancet.
[173] R. Oschmann,et al. Pharmakokinetik von β-Aescin nach Gabe verschiedener Aesculus-Extrakt enthaltender Formulierungen , 1996 .
[174] C. Kole,et al. Antibacterial and antifungal activity of ten essential oils in vitro. , 1996, Microbios.
[175] F. Jung,et al. Leg oedema protection from a buckwheat herb tea in patients with chronic venous insufficiency: a single-centre, randomised, double-blind, placebo-controlled clinical trial , 1996, European Journal of Clinical Pharmacology.
[176] Identification of flavonoid metabolites after oral administration to rats of a Ginkgo biloba extract. , 1995, Journal of chromatography. B, Biomedical applications.
[177] M. Seiberling,et al. [The relative bioavailability and pharmacokinetics of standardized myrtol]. , 1995, Arzneimittel-Forschung.
[178] O. Texier,et al. Quercetin metabolites in plasma of rats fed diets containing rutin or quercetin. , 1995, The Journal of nutrition.
[179] C. Nasel,et al. Concentration of 1,8-cineol in human blood during prolonged inhalation. , 1995, Chemical senses.
[180] J. Fourtillan,et al. [Pharmacokinetic properties of Bilobalide and Ginkgolides A and B in healthy subjects after intravenous and oral administration of Ginkgo biloba extract (EGb 761)]. , 1995, Therapie.
[181] M. Schürer,et al. [The solubility and bioequivalence of silymarin preparations]. , 1995, Arzneimittel-Forschung.
[182] S. Carpenter,et al. Chemiluminescent activation of the antiviral activity of hypericin: a molecular flashlight. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[183] E. Perucca,et al. Plasma concentrations of free and conjugated silybin after oral intake of a silybin-phosphatidylcholine complex (silipide) in healthy volunteers. , 1994, International journal of clinical pharmacology and therapeutics.
[184] J. Brockmöller,et al. Pharmacokinetics of hypericin and pseudohypericin after oral intake of the hypericum perforatum extract LI 160 in healthy volunteers. , 1994, Journal of geriatric psychiatry and neurology.
[185] S. Shapiro,et al. The antimicrobial activity of essential oils and essential oil components towards oral bacteria. , 1994, Oral microbiology and immunology.
[186] K. Kobashi,et al. Silymarin and Its Components Are Inhibitors of β-Glucuronidase , 1994 .
[187] C. Nasel,et al. Functional imaging of effects of fragrances on the human brain after prolonged inhalation. , 1994, Chemical senses.
[188] M. Guillaume,et al. Veinotonic effect, vascular protection, antiinflammatory and free radical scavenging properties of horse chestnut extract. , 1994, Arzneimittel-Forschung.
[189] E. Perucca,et al. Pharmacokinetics of silybin following oral administration of silipide in patients with extrahepatic biliary obstruction. , 1994, Drugs under experimental and clinical research.
[190] E. Feskens,et al. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study , 1993, The Lancet.
[191] G. Flamini,et al. Composition and antimicrobial properties of essential oils of four Mediterranean Lamiaceae. , 1993, Journal of ethnopharmacology.
[192] R. Pabst. Teaching of anatomy , 1992, The Lancet.
[193] K. H. Kimbel,et al. Ginkgo biloba , 1992, The Lancet.
[194] E. Perucca,et al. Pharmacokinetics of silybin in bile following administration of silipide and silymarin in cholecystectomy patients. , 1992, Arzneimittel-Forschung.
[195] M. Arcari,et al. [A new inclusion complex of silibinin and beta-cyclodextrins: in vitro dissolution kinetics and in vivo absorption in comparison with traditional formulations]. , 1992, Bollettino chimico farmaceutico.
[196] H. Mascher,et al. Study on dose-linearity of the pharmacokinetics of silibinin diastereomers using a new stereospecific assay. , 1992, International journal of clinical pharmacology, therapy, and toxicology.
[197] A. Löf,et al. Renal elimination of verbenols in man following experimental α-pinene inhalation exposure , 1992 .
[198] M. Hagberg,et al. Uptake, distribution and elimination of alpha-pinene in man after exposure by inhalation. , 1990, Scandinavian journal of work, environment & health.
[199] P. Muriel,et al. The role of membrane composition in ATPase activities of cirrhotic rat liver: Effect of silymarin , 1990, Journal of applied toxicology : JAT.
[200] P. Muriel,et al. Prevention by silymarin of membrane alterations in acute CCI4 liver damage , 1990, Journal of applied toxicology : JAT.
[201] K. Matsumoto,et al. Comparison of the effects of bilobol and 12-O-tetradecanoylphorbol-13-acetate on skin, and test of tumor promoting potential of bilobol in CD-1 mice. , 1990, The Journal of toxicological sciences.
[202] M. Doyle,et al. Determination of menthol and menthol glucuronide in human urine by gas chromatography using an enzyme-sensitive internal standard and flame ionization detection. , 1990, Journal of chromatography.
[203] J. Barré,et al. Effect of Ginkgo biloba extract on microsomal enzyme induction. , 1989, International journal of clinical pharmacology research.
[204] D. Triggle,et al. The actions of peppermint oil and menthol on calcium channel dependent processes in intestinal, neuronal and cardiac preparations , 1988, Alimentary pharmacology & therapeutics.
[205] C. Shackleton,et al. Hydrolysis of dietary flavonoid glycosides by strains of intestinal Bacteroides from humans. , 1987, The Biochemical journal.
[206] M. Marletta,et al. Inhibition of cytochrome P-450 activity in rat liver microsomes by the naturally occurring flavonoid, quercetin. , 1985, Archives of Biochemistry and Biophysics.
[207] C. Richmond,et al. Delayed release peppermint oil capsules (Colpermin) for the spastic colon syndrome: a pharmacokinetic study. , 1984, British journal of clinical pharmacology.
[208] I. Hirono,et al. Metabolic fate of [14C] quercetin in the ACI rat. , 1983, The Japanese journal of experimental medicine.
[209] M. Takada,et al. On the metabolic detoxication of thymol in rabbit and man. , 1979, The Journal of toxicological sciences.
[210] W. Lang. [Percutaneous absorption of 3H-aescin in mice and rats]. , 1974, Arzneimittel-Forschung.
[211] W. Mennicke,et al. [Pharmacokinetic studies on triatiated aescin in the mouse and rat]. , 1972, Arzneimittel-Forschung.
[212] H. Hövel,et al. [Analytical and biological studies of salicacean drugs, especially salicin. I. Identification, isolation and analysis methods]. , 1972, Pharmaceutica acta Helvetiae.
[213] J. Meyer-Bertenrath,et al. [Enteral resorption of aescin]. , 1970, Arzneimittel-Forschung.
[214] J. Johnston. Studies in natural product chemistry , 1969 .
[215] T. Maclagan. THE TREATMENT OF ACUTE RHEUMATISM BY SALICIN. , 1876 .